Lv11
10 积分 2023-12-29 加入
Plasma ctDNA as a treatment response biomarker in metastatic cancers: evaluation by the RECIST working group
2小时前
待确认
T Cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination With Pembrolizumab in the Phase 1 KEYNOTE-603 Study
2小时前
已完结
Lenvatinib Combined With Transarterial Chemoembolization as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Phase III, Randomized Clinical Trial (LAUNCH)
15天前
已完结
Association of PD-L1 expression with survival benefit from PD-1/PD-L1 inhibitors in advanced cancer: systematic review and meta-analysis of phase III randomized clinical trials
1个月前
已完结
Unleashing the power of immune checkpoints: Post-translational modification of novel molecules and clinical applications
1个月前
已完结
Functions of Immune Checkpoint Molecules Beyond Immune Evasion
1个月前
已完结
Correlation between second and first primary cancer: systematic review and meta-analysis of 9 million cancer patients
1个月前
已完结
Artificial intelligence in histopathology: enhancing cancer research and clinical oncology
1个月前
已完结
Association between Dietary Anthocyanidins and Biliary Cancer Risk in 98,458 Participants: Results from a Prospective Study
2个月前
已关闭
Dissociated response and clinical benefit in patients treated with nivolumab monotherapy
2个月前
已关闭
皖公网安备34019202002308
